Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a sticky patch make your scar look better?

NCT ID NCT03294863

Symptom relief Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a silicone adhesive dressing called Embrace can improve the look of scars after skin surgery. Half of each surgical wound was treated with the device, the other half with standard care. The trial was stopped early, so results are limited, but the goal was to see if the device leads to better scar color, texture, and width.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Embrace Scar Therapy Device (silicone elastomeric dressing)
What this could lead to
If it works, this could offer a simple way to improve scar appearance after skin surgery.
What could go wrong
The trial was terminated early with only 49 participants, so results are limited. The device may not significantly improve scars compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Mar 2017

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * Able to give informed consent themselves * Patient scheduled for cutaneous surgical procedure along a flat surface suitable to application of the embrace with predicted primary closure. * Able to apply dressings themselves. * Willing to return for follow up visits. Exclusion Criteria: * Mentally handicapped * Unable to understand written and oral English * Incarceration * Under 18 years of age * Pregnant Women * Wounds with predicted closure length less than 3 cm * Patients with known adverse reactions to adhesives * Patients with history of collagen vascular disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Linear cutaneous wound are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

injury severe cutaneous adverse reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Linear cutaneous wound

Contacts and locations

Locations

  • University of California, Davis, Department of Dermatology

    Sacramento, California, 95816, United States